CEL — Celadon Pharmaceuticals Share News
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- £9.23m
- £14.01m
- £0.08m
Interim Report for six months ended 30 June 2022
Notice of Results
Brief: Celadon Pharma Re-appoints Tessera Investment As Advisor
Appointment of Tessera Investment Management
Result of AGM
Brief: Celadon Pharmaceuticals SUCCESSFULLY Completes Sixth Harvest From Its Phase 1 Grow Facility
Business Update
Notice of AGM
Brief: Celadon Pharmaceuticals FY Pretax Loss 720,400 Stg
Full year results
Holding(s) in Company
Second Price Monitoring Extn
Price Monitoring Extension
Change of Name
Result of General Meeting
Holding(s) in Company
Director/PDMR Shareholding
Schedule One - Summerway Capital Plc
Second Price Monitoring Extn